Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorectal Cancer
Clinical trial NCT06521866 · RECRUITING
Trial details
- NCT number
- NCT06521866
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-01
- Primary completion
- 2026-08-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.